Suresh Chintalapati

Founder and Chairman

Dr Suresh Chintalapati is a visionary leader and a pioneer in the field of biotechnology. He is the founder of Mabgenex, and serves as its CEO and Chairman since 2018. He is also the President and Chief Business Officer of Triangulum Biopharma, a company that provides preclinical rodent research services, which he founded in 2016. He is a member of the International Advisory Board of Woxsen University, a prestigious institution that offers world-class education and research.

Dr Chintalapati has a wealth of experience in the molecular diagnostics industry, having been a Partner and Chief Strategic Adviser for GenomeSense, a global institute that offers cutting-edge genomic testing and analysis. He also held various roles in business development and commercialization at leading organizations such as Sanford Burnham Prebys Medical Discovery Institute, Illumina and Pathway Genomics.

Dr Chintalapati is not only a successful entrepreneur, but also a distinguished scientist with 15 years of research experience in molecular biology and immunology. He has published over a dozen peer-reviewed papers in reputed journals and conducted his postdoctoral research at Sanford Burnham Prebys Medical Discovery Institute, one of the top biomedical research institutes in the world.

Dr Chintalapati holds an MS in Biotechnology from University of Hyderabad, a PhD in Molecular Biology from Center for Cellular and Molecular Biology (CCMB) and an MBA. He is passionate about advancing science and technology for the benefit of humanity.